{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:42:12Z","timestamp":1787024532974,"version":"build-2736575974"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,9,1]]},"DOI":"10.2169\/internalmedicine.4898-24","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T17:11:55Z","timestamp":1738948315000},"page":"2646-2651","source":"Crossref","is-referenced-by-count":3,"title":["Therapy-related Trilineage Mixed Phenotype Acute Leukemia Treated with Venetoclax and Azacitidine"],"prefix":"10.2169","volume":"64","author":[{"given":"Jotaro","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Department of Hematology, Toranomon Hospital Kajigaya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyosuke","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toranomon Hospital Kajigaya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otoya","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosei","family":"Kageyama","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toranomon Hospital Kajigaya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Taya","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kaji","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Nishida","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Uruga","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Takagi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Ishiwata","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toranomon Hospital Kajigaya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Toranomon Hospital Kajigaya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Takazawa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Wake","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toranomon Hospital Kajigaya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Weinberg OK, Arber DA. Mixed-phenotype acute leukemia: historical overview and a new definition. Leukemia 24: 1844-1851, 2010.","DOI":"10.1038\/leu.2010.202"},{"key":"2","unstructured":"2. WHO Classification of Tumours Editorial Board. Haematolymphoid Tumours WHO Classification of Tumours, 5th Ed, Volume 11. IARC publication, Lyon, 2024."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Matutes E, Pickl WF, Veer MV, et al. Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood 117: 3163-3171, 2011.","DOI":"10.1182\/blood-2010-10-314682"},{"key":"4","unstructured":"4. Gong X, Yan L, Xiao X, Tang Q, Zhao X. Secondary mixed phenotype acute leukemia following chemotherapy for diffuse large B-cell lymphoma: a case report and review of the literature. Int J Clin Exp Pathol 11: 3104-3110, 2018."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yamamoto K, Sada A, Kawano Y, Katayama Y, Shimoyama M, Matsui T. Therapy-related, mixed phenotype acute leukemia with t(1;21)(p36;q22) and RUNX1 rearrangement. Cancer Genet Cytogenet 201: 122-127, 2010.","DOI":"10.1016\/j.cancergencyto.2010.05.011"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cho JH, Hur M, Moon HW, et al. Therapy-related acute leukemia with mixed phenotype and t(9;22)(q32;q11.2): a case report and review of the literature. Hum Pathol 43: 605-609, 2012.","DOI":"10.1016\/j.humpath.2011.07.010"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Briasoulis E, Tzouvara E, Tsiara S, Vartholomatos G, Tsekeris P, Bourantas K. Biphenotypic acute leukemia following intensive adjuvant chemotherapy for breast cancer: a case report and review of the literature. Breast J 9: 241-245, 2003.","DOI":"10.1046\/j.1524-4741.2003.09323.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Fianchi L, Criscuolo M, Fabiani E, et al. Therapy-related myeloid neoplasms: clinical perspectives. Onco Targets Ther 11: 5909-5915, 2018.","DOI":"10.2147\/OTT.S101333"},{"key":"9","unstructured":"9. National Comprehensive Cancer Network. NCCN Guidelines Version 3.2024 Acute Myeloid Leukemia [Internet]. [cited 2024 Jun 16]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/aml.pdf"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lancet JE, Uy GL, Cortes JE, et al. CPX-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia. J Clin Oncol 36: 2684-2692, 2018.","DOI":"10.1200\/JCO.2017.77.6112"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Getta BM, Roshal M, Zheng J, et al. Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning is associated with favorable outcomes in mixed phenotype acute leukemia. Biol Blood Marrow Transplant 23: 1879-1886, 2017.","DOI":"10.1016\/j.bbmt.2017.06.026"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Alexander TB, Gu Z, Iacobucci I, et al. The genetic basis and cell of origin of mixed phenotype acute leukaemia. Nature 562: 373-379, 2018.","DOI":"10.1038\/s41586-018-0436-0"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. McNerney ME, Godley LA, Beau MML. Therapy-related myeloid neoplasms: when genetics and environment collide. Nat Rev Cancer 17: 513-527, 2017.","DOI":"10.1038\/nrc.2017.60"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Mekni S, Kanoun RY, Ladeb S, Belloumi D, Abdeljelil NB, Othman TB. Venetoclax-azacitidine as salvage therapy for relapsed mixed phenotype acute leukemia after a second allogeneic hematopoietic stem cell transplantation: a case report. Blood Res 58: 118-120, 2023.","DOI":"10.5045\/br.2023.2023061"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wu D, Chen W, Chen Z, Li Q. Venetoclax combined with hypomethylating agents for treatment-na\u00efve B\/myeloid mixed phenotype acute leukemia. Case Rep Hematol 2012: 6661109, 2021.","DOI":"10.1155\/2021\/6661109"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Klocke H, Dong ZM, O'Brien C, et al. Venetoclax and decitabine for T\/myeloid mixed-phenotype acute leukemia not otherwise specified (MPAL NOS). Case Rep Hematol 2020: 8811673, 2020.","DOI":"10.1155\/2020\/8811673"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Yan L, Ping N, Zhu M, et al. Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification. Haematologica 97: 1708-1712, 2012.","DOI":"10.3324\/haematol.2012.064485"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Heesch S, Neumann M, Schwartz S, et al. Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization. Ann Hematol 92: 747-758, 2013.","DOI":"10.1007\/s00277-013-1694-4"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Wolach O, Stone RM. How to treat mixed-phenotype acute leukemia. Blood 125: 2477-2485, 2015.","DOI":"10.1182\/blood-2014-10-551465"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/17\/64_4898-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T03:25:11Z","timestamp":1757129111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/17\/64_4898-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":19,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4898-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"article-number":"4898-24"}}